The standard of the Dutch College of General Practitioners on thyroid disorders;NHG-standaard schildklieraandoeningen: Eerste herziening

Huisarts en Wetenschap

Volumn 49, Issue 7, 2006, Pages 361-373

  Wessels, P ^a   Van Rijswijk, E ^a   Boer, A M ^a   Van Lieshout, ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENERAL PRACTITIONER; HUMAN; MEDICAL SCHOOL; PRACTICE GUIDELINE; REVIEW; THYROID DISEASE;

EID: 33747382082     PISSN: 00187070     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Bij verwijzingen naar NHG-producten: zie http://nhg.artsennet.nl.
2. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004;351:241-9.
3. Alexopoulou O, Beguin C, Buysschaert M, Squifflet JP, De Burbure C, De Nayer P, et al. Predictive factors of thyroid carcinoma in non-toxic multi-nodular goitre. Acta Clin Belg 2004;59:84-9.
4. Allahabadia A, Daykin J, Sheppard MC, Cough SC, Franklyn JA. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab 2001;86:3611-7.
5. Anonymus. Commentaren Medicatiebewaking. Houten: Stichting Health Base, 2005.
6. Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, Tijssen JG, et al. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 2005;90:2666-74.
7. Bekedam DJ. Schildklier en zwangerschap. Utrecht: Nederlandse Vereniging voor Obstetrie en Gynaecologie, 2001.
8. Borstlap R, Nijenhuis ThA, Siderius EJ, Van Wouwe JP. Optimale medische begeleiding van kinderen met het syndroom van Down. Tijdschr Kindergeneeskd 2000;68:189-93.
9. Braunwald E. Harrison's principles of internal medicine New York: McGraw-Hill, 2001.
10. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. Philadelphia. Lippincott Williams & Wilkins, 2005.
11. British Thyroid Association. Guidelines for the management of thyroid cancer in adults. London: Royal College of Physicians, 2002.
12. Brouwer JP, Appelhof BC, Hoogendijk WJ, Huyser J, Endert E, Zuketto C, et al. Thyroid and adrenal axis in major depression: a controlled study in outpatients. Eur J Endocrinol 2005;152:185-91.
13. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999;340:424-9.
14. Bunevicius R, Prange AJ. Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism. Int J Neuropsychopharmacol 2000;3:167-74.
15. Bunevicius R, Jakubonien N, Jurkevicius R, Cernicat J, Lasas L, Prange AJ Jr. Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease. Endocrine 2002;18:129-33.
16. Canaris GJ, Steiner JF, Ridgway EC. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med 1997;12:544-50.
17. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006;295:1033-41.
18. Carta MG, Loviselli A, Hardoy MC, Massa S, Cadeddu M, Sardu C, et al. The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future. BMC Psychiatry 2004;4:25.
19. Commissie Farmaceutische Hulp. Farmacotherapeutisch Kompas 2005. Amstelveen: College voor Zorgverzekeringen, 2005.
20. Commissie Verloskunde. Verloskundig Vademecum. Amstelveen: College voor Zorgverzekeringen, 2003.
21. Consorti F, Anello A, Benvenuti C, Boncompagni A, Giovannone G, Moles N, et al. Clinical value of calcifications in thyroid carcinoma and multinodular goiter. Anticancer Res 2003;23:3089-92.
22. Cooper DS. Thyroid hormone, osteoporosis, and estrogen. JAMA 1994;271:1283-4.
23. d'Herbomez M, Forzy G, Gasser F, Massart C, Beaudonnet A, Sapin R. Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations. Clin Chem Lab Med 2003;41:942-7.
24. Dayan CM. Interpretation of thyroid function tests. Lancet 2001;357:619-24.
25. De Gier JJ. Commentaren Medicatiebewaking Pharmacom Medicom 2005/2006. Houten: Stichting Health Base, 2005.
26. De Smet PHG, Stricker BH, Wilderink F, Wiersinga WM. Hyperthyreoïdie tijdens gebruik van Kelp tabletten. Ned Tijdschr Geneeskd 1990;134:1058-9.
27. Dong BJ, Hauck WW, Gambertoglio JG, Gee L, White JR, Bubp JL, et al. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA 1997;277:1205-13.
28. Drexhage HA. Immunologische aspecten van schildklierziekten. In: Wiersinga WM, Krenning EP, redactie. Schildklierziekten. Houten/Diegem: Bohn Stafleu Van Loghum. 1998.
29. Dupuits FM, Pop P, Hasman A, Schouten HJ. A rational request behavior: the development of prediction instruments regarding thyroid function tests in primary care. Methods Inf Med 1999;38:31-6.
30. Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, Galan JM, Barrios V, Sancho J. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med 2005a;142:412-24.
31. Escobar-Morreale HF, Botella-Carretero JI, Del Escobar RF, De Morreale EG. Review: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab 2005b;90:4946-54.
32. Fava M, Labbate LA, Abraham ME, Rosenbaum JF. Hypothyroidism and hyperthyroidism in major depression revisited. J Clin Psychiatry 1995;56:186-92.
33. Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994;330:1731-8.
34. Fraser SA, Kroenke K, Callahan CM, Hui SL, Williams JW Jr, Unutzer J. Low yield of thyroid-stimulating hormone testing in elderly patients with depression. Gen Hosp Psychiatry 2004;26:302-9
35. Gabriele R, Letizia C, Borghese M, De Toma G, Celi M, Izzo L, et al. Thyroid cancer in patients with hyperthyroidism. Horm Res 2003;60:79-83.
36. Gomez JM, Gomez N, Amat M, Biondo S, Rafecas A, Jaurrieta E, et al. Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism. Ann Endocrinol (Paris) 2000;61:184-91.
37. Gussekloo J, Van Exel E, De Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004;292:2591-9.
38. Gussekloo J, Van Exel E, De Craen AJ, Meinders AE, Frolich M, Westendorp RG. Schildklierfunctie, dagelijks functioneren en overleving van de oudste ouderen; de 'Leiden 85-plus Studie' Ned Tijdschr Geneeskd 2006;150:90-6.
39. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000;132:270-8.
40. Hall R, Besser M, redactie. Fundamentals of clinical endocrinology. Edinburgh: Churchill Livingstone, 1989.
41. Hennemann G. Hypothyreoïdie bij volwassenen In: Wiersinga WM, Krenning EP, redactie. Schildklierziekten. Houten/Diegem: Bohn Stafleu Van Loghum, 1998.
42. Hofmann PJ, Nutzinger DO, Kotter MR, Herzog G. The hypothalamic- pituitary-thyroid axis in agoraphobia, panic disorder, major depression and normal controls. J Affect Disord 2001;66:75-7
43. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99.
44. Holm IA, Manson JE, Michels KB, Alexander EK, Willett WC, Utiger RD. Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism. Arch Intern Med 2005;165:1606-11.
45. Hoogendoorn EH, Wiersinga WM, Prummel MF, Den Heijer M, Corstens FH, Hermus AR. Subklinische hyperthyreoïdie; start van klinische trial naar het nut van behandeling met radioactief jood. Ned Tijdschr Geneeskd 2004;148:953-4
46. Kabadi UM. 'Subclinical hypothyroidism'. Natural course of the syndrome during a prolonged follow-up study. Arch Intern Med 1993;153:957-61.
47. Karlsson B, Gustafsson J, Hedov G, Ivarsson SA, Anneren G. Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 1998;79:242-5.
48. Kim WB, Han SM, Kim TY, Nam-Goong IS, Gong G, Lee HK et al. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease. Clin Endocrinol (Oxf) 2004;60:719-25.
49. Kimball LE, Kulinskaya E, Brown B, Johnston C, Farid NR. Does smoking increase relapse rates in Graves' disease? J Endocrinol Invest 2002;25:152-7
50. Klein I, Danzi S. Evaluation of the therapeutic efficacy of different levothyroxine preparations in the treatment of human thyroid disease. Thyroid 2003;13:1127-32.
51. Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie. Informatorium Medicamentorum. Den Haag: KNMP, 2005.
52. Kratzsch J, Fiedler GM, Leichtle A, Brugel M, Buchbinder S, Otto L, et al. New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 2005;51:1480-6
53. Krenning EP, Hennemann G. Thyreostatica. Geneesmiddelenbulletin 1986;20:63-8
54. Kumpulainen EJ, Hirvikoski PP, Virtaniemi JA, Johansson RT, Simonen PM, Terava MT, et al. Hypothyroidism after radiotherapy for laryngeal cancer Radiother Oncol 2000;57:97-101
55. Kung AW, Yau CC, Cheng AC. The action of methimazole and L-thyroxine in radioiodine therapy a prospective study on the incidence of hypothyroidism. Thyroid 1995;5:7-12.
56. Laurberg P. Global or Gaelic epidemic of hypothyroidism? Lancet 2005;365:738-40.
57. Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC, Cowden EA. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. J Clin Endocrinol Metab 2003;88:978-83.
58. Lucas A, Pizarro E, Granada ML, Salinas I, Foz M, Sanmarti A. Postpartum thyroiditis: epidemiology and clinical evolution in a nonselected population. Thyroid 2000;10:71-7.
59. McIver B, Rae P, Beckett G, Wilkinson E, Gold A, Toft A. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. N Engl J Med 1996;334:220-4.
60. Mercado G, Adelstein DJ, Saxton JP, Secic M, Larto MA, Lavertu P. Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer 2001;92:2892-7.
61. Mookhoek EJ, Sterrenburg-van der Nieuwegiessen IM. Screening for somatic disease in elderly psychiatric patients. Gen Hosp Psychiatry 1998;20:102-7.
62. Nygaard B, Hegedus L, Gervil M, Hjalgrim H, Hansen BM, Soe-Jensen P, et al. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease. J Intern Med 1995;238:491-7.
63. Ordas DM, Labbate LA. Routine screening of thyroid function in patients hospitalized for major depression or dysthymia? Ann Clin Psychiatry 1995;7:161-5
64. Othman S, Phillips DI, Parkes AB, Richards CJ, Harris B, Fung H, et al. A long-term follow-up of postpartum thyroiditis. Clin Endocrinol (Oxf) 1990;32:559-64.
65. Pearce EN, Harwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003;348:2646-55.
66. Peccin S, De Castsro JA, Furlanetto TW, Furtado AP, Brasil BA, Czepielewski MA. Ultrasonography: is it useful in the diagnosis of cancer in thyroid nodules? J Endocrinol Invest 2002;25:39-43.
67. Perrild H, Hegedus L, Baastrup PC, Kayser L, Kastberg S. Thyroid function and ultrasonically determined thyroid size in patients receiving long-term lithium treatment. Am J Psychiatry 1990;147:1518-21.
68. Pop VJ, De Rooy HA, Vader HL, Van der Heide D, Essed GG, De Geus CA. Voorkomen van postpartale schildklierfunctiestoornissen in Nederland. Ned Tijdschr Geneeskd 1992;136:917-21.
69. Premawardhana LD, Parkes AB, Ammari F, John R, Darke C, Adams H, et al. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab 2000;85:71-5.
70. Prummel MF, Wiersinga WM, Krenning EP. Hyperthyreoidie. In: Wiersinga WM, Krenning EP, redactie. Schildklierziekten. Houten/Diegem: Bohn Stafleu Van Loghum, 1998.
71. Rasmussen NG, Hornnes PJ, Hoier-Madsen M, Feldt-Rasmussen U, Hegedus L. Thyroid size and function in healthy pregnant women with thyroid autoantibodies. Relation to development of postpartum thyroiditis. Acta Endocrinol (Copenh) 1990;123:395-401.
72. Rege V, Mojiminiyi O, Wilcox H, Barron J. Comparison of Kodak Amerlite FT4 and TSH-30 with T4 and TSH as first-line thyroid function tests. Clin Biochem 1996;29:1-4.
73. Roos A, Linn-Rasker SP, Van Domburg RT, Tijssen JP, Berghout A. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med 2005;165:1714-20.
74. Rubello D, Pozzan GB, Casara D, Girelli ME, Boccato S, Rigon F, et al. Natural course of subclinical hypothyroidism in Down's syndrome: prospective study results and therapeutic considerations. J Endocrinol Invest 1995;18:35-40.
75. Safran M, Paul TL, Roti E, Braverman LE. Environmental factors affecting autoimmune thyroid disease. Endocrinol Metab Clin North Am 1987;16:327-42.
76. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on 'adequate' doses of I-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 2002;57:577-85.
77. Sawka AM, Gerstein HC, Marriott MJ, MacQueen GM, Joffe RT. Does a combination regimen of thyroxine (T4) and 3,5,3′-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003;88:4551-5.
78. Schaefer C. Drugs during pregnancy and lactation, handbook of prescription drugs and comparative risk assessment. Amsterdam: Elsevier Science, 2001.
79. Schneider DL, Barrett-Connor EL, Morton DJ. Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen. JAMA 1994;271:1245-9.
80. Shahbazian HB, Sarvghadi F, Azizi F. Prevalence and characteristics of postpartum thyroid dysfunction in Tehran. Eur J Endocrinol 2001;145:397-401.
81. Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, et al. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf) 2004;60:750-7.
82. Slee PHThJ, Wiltink EHH. Levothyroxine hoeft niet half uur voor ontbijt. Pharmaceutisch Weekblad 2005;140:1288-9.
83. Stocker DJ, Burch HB. Thyroid cancer yield in patients with Graves' disease. Minerva Endocrinol 2003;28:205-12.
84. e druk. London: Blackwell Scientific Publications, 2005.
85. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med 1995;333:1688-94.
86. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-38.
87. Tavintharan S, Sundram FX, Chew LS. Radioiodine (I-131) therapy and the incidence of hypothyroidism. Ann Acad Med Singapore 1997;26:128-31.
88. Tell R, Lundell G, Nilsson B, Sjodin H, Lewin F, Lewensohn R. Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;60:395-400.
89. The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Falls Church. The American Thyroid Association Guidelines Taskforce, 2005.
90. Toft AD. Thyroxine therapy. N Engl J Med 1994;331:174-80.
91. Van der Heide D. Jodium en schildklierhormoon In: Wiersinga WM, Krenning EP, redactie. Schildklierziekten. Houten/Diegem: Bohn Stafleu Van Loghum, 1998.
92. Van der Linden MW, Westert GP, De Bakker DH, Schellevis FG. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk: klachten en aandoeningen in de bevolking en in de huisartspraktijk. Utrecht/Bilthoven: NIVEL/Rijksinstituut voor Volksgezondheid en Milieu, 2004.
93. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43:55-68.
94. Vereniging van Integrale Kankercentra. Age standardized incidence rates (ESR) for invasive tumours according to site in females and to site in males and females 1989-2003. http://www.ikcnet.nl.
95. Vestergaard P. Smoking and thyroid disorders - a meta-analysis. Eur J Endocrinol 2002;146:153-61.
96. Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, et al. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 2003;88:4543-50.
97. Wartofsky L. Levothyroxine therapy for hypothyroidism: should we abandon conservative dosage titration? Arch Intern Med 2005;165:1683-4.
98. Wekking EM, Appelhof BC, Fliers E, Schene AH, Huyser J, Tijssen JG, et al. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol 2005;153:747-53.
99. Wessels P, Grundmeijer HGLM. Schildklieraandoeningen in zes huisartspraktijken. Huisarts Wet 2000;43:203-6.
100. Wiersinga WM. Geneesmiddelen bij schildklieraandoeningen. Ned Tijdschr Geneeskd 1986;130:2163-6.
101. Wiersinga WM. Schildklieraandoeningen als contra-indicatie. In: De Smet PAGM, Van Loenen AC, Offerhaus L, Van der Does E, redactie. Medicatie begeleiding. Houten/Deurne: Bohn Stafleu Van Loghum, 1990.
102. Wiersinga WM. Propranolol and thyroid hormone metabolism. Thyroid 1991;1:273-7.
103. Wiersinga WM, Krenning EP. Hyperthyroidie. In: Wiersinga WM, Krenning EP, redactie. Schildklierziekten. Houten/Diegem: Bohn Stafleu Van Loghum, 1998a.
104. Wiersinga WM, Krenning EP. Thyreotoxicosis. In: Wiersinga WM, Krenning EP, redactie. Schildklierziekten. Houten/Diegem: Bohn Stafleu Van Loghum, 1998b.
105. Wiersinga WM, Corssmit EP, Boer K, Prummel MF. Tijdige herkenning en behandeling van zwangeren met hypothyreoïdie: het belang voor het kind. Ned Tijdschr Geneeskd 2001;145:713-6.
106. Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves' ophthalmopathy. Thyroid 2002;12:855-60.
107. Wiersinga WM. Adult hypothyroidism. The thyroid and its diseases (2004). http://www.thyroidmanager.org/Chapter9.
108. Wiersinga WM. Onzekerheden over het nut van behandeling van subklinische schildklierfunctiestoornissen. Ned Tijdschr Geneeskd 2006;150:71-4.
109. Wilson GR, Curry RW Jr. Subclinical thyroid disease. Am Fam Physician 2005;72:1517-24.
110. Wizemann TM, Pardue M-L. Sex affects health. Exploring the biological contributions to human health. Does sex matter? Washington: National Academy Press, 2001.
111. Zulewski H, Muller B, Exer P, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 1997;82:771-6.